Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Nasacort approved in 2- to 5-year-olds
A new allergy drug for children will soon be on the market: The FDA has approved Sanofi-Aventis' Nasacort for children between the ages of 2 and 5 years old for the treatment of allergies. The FDA previously approved the medication for the treatment of individuals who were at least 6 years old. Sanofi release
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
